New Hampshire 2023 Regular Session

New Hampshire House Bill HB426

Introduced
1/10/23  
Refer
1/10/23  
Report Pass
3/14/23  
Engrossed
3/24/23  
Refer
3/24/23  
Report Pass
4/26/23  
Enrolled
6/28/23  
Chaptered
8/1/23  

Caption

Relative to the regulation of pharmacists-in-charge and pharmacies.

Impact

The bill enacts changes to disciplinary action protocols significantly. By replacing references to 'pharmacist-in-charge' with 'permit holder,' the bill shifts the focus of accountability for misconduct from individual pharmacists to the owning or managing entity of the pharmacy. This reflects an intention to hold businesses accountable for adhering to safety and professional standards, potentially leading to more standardized practices across the state’s pharmacy sector.

Summary

House Bill 426 seeks to amend existing state regulations concerning pharmacists and pharmacies, primarily adjusting the definitions relevant to pharmacy permit holders. The bill redefines 'permit holder' to refer specifically to the entity that owns or operates a pharmacy in the state, ensuring clarity regarding who is responsible for operational compliance and the facility's oversight. This adjustment aims to tighten the accountability of pharmacy operations under state regulation while also clarifying the responsibilities associated with pharmacy management.

Contention

While proponents of HB 426 argue that these changes enhance accountability and patient safety by ensuring that the managing entity is responsible for regulatory compliance, there are concerns about the potential implications for the individual pharmacists employed within these establishments. Critics may fear that these changes could dilute the personal accountability of licensed pharmacists, as the onus shifts to the corporate structures behind pharmacies. In addition, the bill discusses the removal of certain provisions regarding the direct role of pharmacists-in-charge, which could raise concerns about oversight in pharmacy practices and patient care quality.

Enforcement

With the introduction of Continuous Quality Improvement (CQI) programs as mandated by the bill, pharmacies will need to implement processes to systematically monitor and enhance service quality. These programs require periodic reviews of quality-related events to ensure compliance with regulations. This aspect of the bill aims to ensure that pharmacies actively engage in practices that enhance medication safety and service effectiveness, reflecting an evolving approach to health care regulation that prioritizes continuous assessment and improvement.

Companion Bills

No companion bills found.

Similar Bills

CA AB690

Pharmacies: relocation: remote dispensing site pharmacy: pharmacy technician: qualifications.

MS HB1125

Pharmacy services; prohibit insurers and PBMs from requiring persons to obtain exclusively through pharmacies that they own.

CA AB529

Pharmacy: declared state of emergency.

CA AB3026

Pharmacy.

CA AB401

Pharmacy: remote dispensing site pharmacy: telepharmacy: shared clinic office space.

WV HB4324

To update collaborative pharmacy practice agreements

MD SB690

Pharmacy Benefits Managers - Definitions of Carrier, ERISA, and Purchaser

MD HB1014

Pharmacy Benefits Managers – Definitions of Carrier, ERISA, and Purchaser